EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CNSP:

27 Aug 2025
LAST:

6.290

CHANGE:
 0.17		OPEN:
6.250		HIGH:
6.385		ASK:
0.000		VOLUME:
9.8K
CHG(%):
2.78		PREV:
6.120		LOW:
5.850		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
27 Aug 256.2506.3855.8506.2909.8K
26 Aug 256.4806.4956.1026.12023.4K
25 Aug 256.2306.7006.0406.54049.7K
22 Aug 256.4606.6505.7606.48079.8K
21 Aug 256.2806.5005.8106.070844.8K
20 Aug 255.4107.3205.4106.970123.7K
19 Aug 256.1906.1905.3105.41026.6K
18 Aug 255.3106.2505.1106.19082.1K
15 Aug 256.3106.3294.9305.09077.1K
14 Aug 257.1507.7455.7286.03084.3K

COMPANY PROFILE

Name:
About:CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Sector:Healthcare
Industry:Biotechnology
Address:2100 West Loop South, Houston, TX, United States, 77027
Website:https://www.cnspharma.com
CUSIP:18978H102
CIK:0001729427
ISIN:US18978H1023
FIGI:BBG00PM24T16

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:0.00
PtB:0.22
Shares:529.8K
Market Cap:3.33M

TECHNICAL INDICATORS

MA5:6.30
MA10:6.12
MA20:6.66
MA50:4.22
MA100:2.64
MA200:1.74
STO9:53.81
STO14:45.20
RSI14:45.48
WPR14:-36.17
MTM14:-0.41
ROC14:-0.06
ATR:0.98
Week High:7.32
Week Low:5.41
Month High:9.08
Month Low:4.93
Year High:9.62
Year Low:0.07
Volatility:881.43

RECENT SPLITS

Date Ratio
21 Feb 20251-50
05 Jun 20241-50
29 Nov 20221-30